Anti-cancer and anti-metastatic (via IGF1/IGF-1R system inhibition and via estrogen receptors)Inhibit Akt signaling pathwayInhibit carbonic anhydrase and acetylcholinesteraseAnti-diabetic (via AMPK signaling). Here, AKT1 is linked to cancer.